| 000 | 01871 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514162451.0 | ||
| 264 | 0 | _c20040220 | |
| 008 | 200402s 0 0 eng d | ||
| 022 | _a0169-328X | ||
| 024 | 7 |
_a10.1016/j.molbrainres.2003.08.021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHara, Hirokazu | |
| 245 | 0 | 0 |
_aIncrease of antioxidative potential by tert-butylhydroquinone protects against cell death associated with 6-hydroxydopamine-induced oxidative stress in neuroblastoma SH-SY5Y cells. _h[electronic resource] |
| 260 |
_bBrain research. Molecular brain research _cNov 2003 |
||
| 300 |
_a125-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntioxidants _xpharmacology |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aGlutathione _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroquinones _xpharmacology |
| 650 | 0 | 4 | _aJNK Mitogen-Activated Protein Kinases |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xmetabolism |
| 650 | 0 | 4 | _aModels, Neurological |
| 650 | 0 | 4 |
_aNAD(P)H Dehydrogenase (Quinone) _xgenetics |
| 650 | 0 | 4 | _aNeuroblastoma |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 | _aOxidopamine |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 |
_aRNA, Messenger _xdrug effects |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 |
_aTranscriptional Activation _xdrug effects |
| 700 | 1 | _aOhta, Mitsuhiro | |
| 700 | 1 | _aOhta, Kiyoe | |
| 700 | 1 | _aKuno, Sadako | |
| 700 | 1 | _aAdachi, Tetsuo | |
| 773 | 0 |
_tBrain research. Molecular brain research _gvol. 119 _gno. 2 _gp. 125-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.molbrainres.2003.08.021 _zAvailable from publisher's website |
| 999 |
_c14361774 _d14361774 |
||